1. Home
  2. TONX vs CLLS Comparison

TONX vs CLLS Comparison

Compare TONX & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TON Strategy Company

TONX

TON Strategy Company

N/A

Current Price

$3.22

Market Cap

147.6M

ML Signal

N/A

Logo Cellectis S.A.

CLLS

Cellectis S.A.

N/A

Current Price

$1.13

Market Cap

139.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TONX
CLLS
Founded
N/A
1999
Country
United States
France
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.6M
139.0M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
TONX
CLLS
Price
$3.22
$1.13
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $4.83
AVG Volume (30 Days)
★ 258.1K
87.1K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 69.21
N/A
EPS
N/A
★ N/A
Revenue
★ $32,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.70
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 433.33
N/A
52 Week Low
$1.75
$0.88
52 Week High
$4.44
$5.45

Technical Indicators

Market Signals
Indicator
TONX
CLLS
Relative Strength Index (RSI) 50.91 47.78
Support Level $3.15 $0.94
Resistance Level $3.60 $1.28
Average True Range (ATR) 0.33 0.12
MACD 0.07 0.06
Stochastic Oscillator 45.51 40.01

Price Performance

Historical Comparison
TONX
CLLS

About TONX TON Strategy Company

TON Strategy Co is a digital asset treasury and Web3 ecosystem company focused on supporting The Open Network, a public blockchain integrated with Telegram and designed for fast, scalable transactions and decentralized applications. Its core business is managing its holdings of Toncoin (TON), including staking tokens to support network validation and earn rewards, while adhering to regulatory, accounting, and risk management standards. The company also pursues Web3 initiatives to support the ecosystem's growth and adoption. It operates through MARKET. live, Go Fund Yourself, and TON segments, with MARKET.live generating maximum revenue as a multi-vendor livestream shopping platform that combines e-commerce and entertainment across social and video channels.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: